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A B S T R A C T
The yeast peroxiredoxin Ahp1, like related anti-oxidant enzymes in other species, undergoes urmylation, a ly-
sine-directed conjugation to ubiquitin-like modifier Urm1. Ahp1 assembles into a homodimer that detoxifies
peroxides via forming intersubunit disulfides between peroxidatic and resolving cysteines that are subsequently
reduced by the thioredoxin system. Although urmylation coincides with oxidative stress, it is unclear how this
modification happens on a molecular level and whether it affects peroxiredoxin activity. Here, we report that
thioredoxin mutants decrease Ahp1 urmylation in yeast and each subunit of the oxidized Ahp1 dimer is modified
by Urm1 suggesting coupling of urmylation to dimerization. Consistently, Ahp1 mutants unable to form dimers,
fail to be urmylated as do mutants that lack the peroxidatic cysteine. Moreover, Ahp1 urmylation involves at
least two lysine residues close to the catalytic cysteines and can be prevented in yeast cells exposed to high
organic peroxide concentrations. Our results elucidate redox requirements and molecular determinants critical
for Ahp1 urmylation, thus providing insights into a potential link between oxidant defense and Urm1 utilization
in cells.
1. Introduction
Glutathione peroxidases and peroxiredoxins are highly conserved
thiol-dependent proteins, which detoxify various reactive oxygen spe-
cies (ROS) and thus are critical to maintain cellular redox homeostasis
[1–3]. Accordingly, organisms with defects in these anti-oxidant en-
zymes exhibit premature aging, impaired growth and compromised
fitness [4–6]. The yeast Saccharomyces cerevisiae expresses several thiol-
dependent oxidoreductases, including glutathione peroxidases (Gpx1-
Gpx3) and various peroxiredoxins (Ahp1, Dot5, Prx1, Tsa1, Tsa2) [7].
Their number together with differential localization and expression
patterns suggests functional plasticity in protection against various ROS
including H2O2 or organic peroxides [8]. In support of this notion, Gpx3
and Tsa1 display broad ROS substrate specificities, while Ahp1 pre-
ferentially reduces organic peroxides (e.g. tert-butyl hydroperoxide [t-
BOOH]) [9–13].
Ahp1 is a typical 2-Cys peroxiredoxin, which forms constitutive
homodimers by employing phenylalanine residues (Phe-58, Phe-95)
that build a hydrophobic dimerization interface (Fig. 1A and B) for
precise positioning of the two subunits [14,15]. Each Ahp1 subunit
carries resolving (Cys-31: CR) and peroxidatic (Cys-62: CP) thiols critical
for anti-oxidant function [11,12,15,16] (Fig. 1B). During t-BOOH de-
toxification, the CP thiols become sulfenylated (-SOH), form Ahp1 in-
tersubunit disulfides with the CR thiols and are reduced for a new
peroxidatic cycle by thioredoxin (Fig. 1B). Ahp1 also undergoes post-
translational modifications, including S-glutathionylation [14] and ur-
mylation. The latter involves lysine-directed conjugation of ubiquitin-
related modifier Urm1 [17–22].
Urm1 has two distinct cellular roles, namely as a post-translational
protein modifier and as a sulfur donor for a thiolase (Ncs2-Ncs6), which
in concert with the Elongator complex (Elp1-Elp6) adds thiomodifica-
tions to wobble uridines in tRNA anticodons [23–28]. Importantly,
tRNA thiolation and protein urmylation require sulfur activation and
transfer onto the C-terminus of Urm1 by Uba4, an E1-like activator
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protein that produces thiocarboxylated Urm1 (Urm1-COSH)
[17,19,21,29]. Thus, the two Urm1 functions are chemically linked by
sulfur transfer and potentially coupled to oxidative stress
[19,21,22,30,31].
Consistently, intracellular ROS and other thiol-reactive agents (e.g.
N-ethylmaleimide [NEM], diamide) trigger urmylation in eukaryotes.
Among others, Urm1 targets from yeast, fungi, flies or human cells
include oxidative stress response factors like hemopexin, carbonyl re-
ductase and 2-Cys peroxiredoxins (e.g. Prx5, Ahp1) [18–22,32,33].
Urm1•Uba4 modifier systems are exchangeable from yeast to plant and
human cells, and, when expressed in yeast, human URM1 conjugates
with Ahp1, indicating that protein urmylation is a process conserved
among eukaryotes [19,20,34]. Furthermore, the identification of pro-
karyotic Urm1 or Uba4 counterparts implies that Urm1-like systems
and protein urmylation are found throughout evolution [35–37].
Although its biological function remains elusive, it is accepted that
urmylation does not act as an ubiquitin-like tag for protein degradation
in eukaryotes [18,20,38]. An Urm1 acceptor site identified in Ahp1
(Lys-32) [21] maps next to the CR (Cys-31) (Fig. 1B), suggesting ur-
mylation may interfere with the enzyme's peroxidase activity [15].
Even though urmylation coincides with oxidative stress, it is unknown
whether it affects the activity of peroxiredoxins in yeast, insects or
human cells. Therefore, we examined urmylation in further detail in S.
cerevisiae and found that the ability of Ahp1 to form dimers with intact
redox-active centers is intimately linked to Urm1 acceptor activity. In
addition, Urm1 target site analysis reveals two residues (Lys-32, Lys-
156) in proximity to the redox-active center, which when mutated in
Ahp1 drastically decrease urmylation without compromising protection
against t-BOOH. Our data indicate that oxidative stress and anti-oxidant
activity of Ahp1 are required for urmylation.
Fig. 1. Ahp1 structure, redox states and in vivo urmylation. (A) Overview of the Ahp1 homodimer (PDB #4DSR, 4DSQ) composed of two subunits (magenta & beige).
Highlighted are residues critical for dimerization (F58 & F95: teal), peroxidase activity (C31 & C62: orange) or known urmylation (K32: red). (B) The enlargement
(top panel) shows the redox-active centers formed between each subunit by resolving (C31) and peroxidatic (C62) thiols. Upon oxidation by ROS (t-BOOH), they
become disulfide-bridged (bottom panel) and can be reduced by the thioredoxin system (see Fig. 2A). (C) Formation of HA-Urm1•Ahp1 conjugates in vivo. Shown are
EMSAs under reducing (left panels) and non-reducing (right panels) conditions on protein extracts from indicated strains expressing HA-URM1 (+) or not (−). NEM-
stabilized urmylation was studied by anti-HA blots (top panels) diagnostic for free HA-Urm1 (~17 kDa) and urmylated forms of Ahp1 (~36 kDa) or Ahp1 inter-
subunit disulfide (AID ~72 kDa) as well as Urm1-modified c-Myc tagged Ahp1 (~43 kDa) or AID (~90 kDa) forms. anti-Ahp1 Western blots (middle panels) detect
unmodified Ahp1 (~19 kDa) and AID (~38 kDa) or c-Myc tagged Ahp1 (~27 kDa) and AID (~54 kDa). Protein loading control used anti-Cdc19 blots (bottom
panels). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 2. Thioredoxin function supports Ahp1 urmylation. (A) Ahp1 oxidation by
ROS (t-BOOH) and reduction by the thioredoxin system, i.e. NADPH-dependent
thioredoxin reductase (Trr1) and thioredoxins (Trx1; Trx2). (B) EMSAs under
reducing (left panels) and non-reducing (right panels) conditions with protein
extracts of indicated strains expressing HA-URM1 (+) or not (−). Urmylation
was studied by anti-HA (top panels) diagnostic for free HA-Urm1 and urmylated
forms of Ahp1 (~36 kDa) or Ahp1 intersubunit disulfides (AID ~72 kDa). anti-
Ahp1 blots (middle panels) detect unmodified Ahp1 (~19 kDa) and AIDs
(~38 kDa). anti-Cdc19 (bottom panels) served as loading control. Asterisks
denote faster migrating Ahp1 forms.
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2. Results
2.1. Urm1•Ahp1 conjugation based on electrophoretic mobility shift assays
(EMSA)
In the presence of isopeptidase inhibitor NEM, Ahp1 is among the
most prominent Urm1 targets in S. cerevisiae [18,19,21]. Previous stu-
dies used β-mercaptoethanol (β-ME) or dithiothreitol (DTT), reducing
agents that impede analysis of Urm1 conjugation to Ahp1 intersubunit
disulfides [18–21]. Since these disulfides form during the Ahp1 cata-
lytic cycle [15,39,40] (Fig. 1B), we compared urmylation under redu-
cing conditions (standard SDS-PAGE with β-ME in sample buffer) and
non-reducing ones (without β-ME) in yeast cells expressing HA-tagged
Urm1 (Fig. 1C). In the presence of NEM and β-ME, anti-HA EMSA
distinguished free HA-Urm1 (~17 kDa) from a major HA-Urm1 con-
jugate (~36 kDa) that is absent from the ahp1Δ null-mutant and up-
shifted (~43 kDa) upon c-Myc tagging in AHP1-c-myc cells (Fig. 1C).
Thus, the ~36 kDa band represents an Urm1 modified Ahp1 subunit
most likely originating under reducing SDS-PAGE conditions from an
urmylated dimer.
Accordingly, under non-reducing conditions, we detected a slower
migrating HA-Urm1•Ahp1 conjugate roughly double in size (~72 kDa),
which is absent from ahp1Δ cells and up-shifted (~90 kDa) upon c-Myc
tagging (Fig. 1C). This conjugate corresponds to an oxidized dimer with
both Ahp1 subunits urmylated and interlinked by disulfides that are
sensitive to reduction by β-ME (Fig. 1C). Oxidized Ahp1 dimers de-
tected by anti-Ahp1 EMSA lack urmylation (Fig. 1C), suggesting that
attachment of HA-Urm1 (~17 kDa) blocks Ahp1 (~19 kDa) recognition
and immune detection by the antiserum [39]. As unmodified Ahp1
remains detectable under our experimental conditions there seems to be
an equilibrium of free and urmylated Ahp1 in vivo. In support of this
notion, independent studies with TAP-tagged Urm1 show differential
Ahp1 conjugates including Ahp1 disulfides, which under non-reducing
conditions, have one TAP-Urm1 copy attached to each subunit (Suppl.
Fig. S1). The occurrence of detectable disulfide-linked dimers modified
by Urm1 implies that urmylation does not affect the redox-active thiols
required for disulfide formation. Collectively, our data uncover dis-
ulfide bridged Ahp1•Urm1 conjugates that coexist with a pool of the
Ahp1 peroxiredoxin that is not modified by Urm1.
2.2. Defects in the thioredoxin system affect Urm1 conjugation to Ahp1
Urm1 is attached to oxidized Ahp1 intermediates (Fig. 1C) that may
be subject to reduction by the cytosolic thioredoxin system (Trx1, Trx2,
Trr1) (Fig. 2A) [7]. Therefore, we examined urmylation in yeast strains
lacking a functional thioredoxin system. As judged from anti-Ahp1 and
anti-HA EMSAs, Ahp1 urmylation and expression levels did not differ in
mutants lacking thioredoxin Trx1 (trx1Δ) or Trx2 (trx2Δ) (Fig. 2B).
However, loss of both reducing enzymes (trx1Δtrx2Δ) or thioredoxin
reductase (trr1Δ) lowered urmylation mildly and significantly increased
formation of non-modified intersubunit disulfides (Fig. 2B). Accord-
ingly, urmylated disulfides decreased with trx1Δtrx2Δ or trr1Δ mutants
(Fig. 2B). Thus, our data indicate proper recycling of Ahp1 by the
thioredoxin system impacts Urm1 conjugation, in particular the for-
mation of urmylated Ahp1 intersubunit disulfides (Fig. 2B).
2.3. Dose-dependent suppression of Ahp1 urmylation by t-BOOH
Prompted by data that exposure with the organic peroxide t-BOOH
stimulates the formation of Ahp1 intersubunit disulfides [39], we next
studied the impact of oxidative stress on Ahp1 urmylation in vivo. Using
anti-HA and anti-Ahp1 EMSAs under reducing and non-reducing con-
ditions, mild t-BOOH levels (0.3–0.6 mM) did not affect Ahp1 urmy-
lation (Fig. 3). Intermediate t-BOOH doses (1.2–2.5 mM), however,
progressively suppressed Ahp1 urmylation and formation of inter-
subunit disulfides, and highest doses (5–10 mM) eventually abolished
both (Fig. 3). Thus, t-BOOH doses known to affect yeast cell growth in
vivo [14] efficiently suppress Urm1 conjugation and Ahp1 disulfide
formation (Fig. 3). Whether this involves t-BOOH interference with
Ahp1, the thioredoxin system or Urm1-COSH, the thiocarboxylate cri-
tical for Ahp1 urmylation, is not known. In an effort to address these
options, we found that lack of thioredoxin reductase Trr1 in the trr1Δ
mutant counteracts the negative t-BOOH effect on urmylation seen with
TRR1 wild-type cells (Fig. 4A). As a result, HA-Urm1•Ahp1 conjugates
and Ahp1 disulfides reappeared and even increased in relation to the
untreated trr1Δ control (Fig. 4A). Thus, inhibition of urmylation by t-
BOOH apparently relies on thioredoxin function.
Our data suggest Ahp1 hyperoxidation by t-BOOH in vivo since the
intersubunit disulfides that are locked in the trr1Δ mutant (Fig. 4A)
ought to resist oxidation. In line with this notion, excess t-BOOH pre-
viously led to conversion of the CP thiol (Cys-62) into a sulfonate in vitro
[12,41]. Hence, hyperoxidation may be ascribable, at least in part, for
the inhibitory t-BOOH effects that we observe in vivo on urmylation of
Ahp1 (Fig. 3). Alternatively, t-BOOH may interfere with Urm1-COSH,
which is crucial for Ahp1 urmylation in vivo [19,21]. To study the latter,
we exposed recombinant Urm1-COSH to t-BOOH and analyzed it by an
APM-based gel retardation assay that distinguishes the starting material
(Urm1-COSH) from the inactive form (Urm1-COOH) [42]. t-BOOH
doses (1.2–2.5 mM) found to be effective in vivo (Fig. 3) gradually
converted Urm1-COSH into mobile Urm1-COOH (Fig. 4B). At t-BOOH
doses (5–10 mM) that abolished urmylation in vivo (Fig. 3), Urm1-
COOH exclusively accumulated in vitro (Fig. 4B). With the latter being
unable to urmylate proteins (including Ahp1) [19,21,29], our in vitro
data (Fig. 4B) suggest that the t-BOOH effect in vivo (Fig. 3) may involve
inactivation of Urm1. Collectively, high organic peroxide doses appear
to prevent urmylation in yeast cells through a combination of negative
effects on Urm1 and Ahp1.
2.4. The dimer interface is required for peroxidase and Urm1 acceptor
activity of Ahp1
To investigate redox requirements of Ahp1 for Urm1 conjugation we
asked whether urmylation is linked to dimerization of Ahp1. To do so,
we resorted to structural data [14,15] showing that two conserved
phenylalanine residues (Phe-58, Phe-95) (Fig. 1A and B) are located at
the center of the dimer interface. When mutated (F58A; F95A;
F58,95A), these were shown by native PAGE analysis to cause de-
creased dimerization [14]. To validate and extend the data, we esti-
mated the molecular weights of wild-type Ahp1 and interface mutants
via SEC-MALS (Fig. 5A), a technique coupling size exclusion chroma-
tography with multiangle light scattering [43]. Despite a broad reten-
tion profile of wild-type Ahp1, the molecular weights for both distin-
guishable peaks via MALS analysis were in line with the value of an
Ahp1 homodimer (46.7 kDa) (Fig. 5A).
In contrast, each of the interface mutants eluted at retention times
comparable to wild-type Ahp1, yet as single peaks (Fig. 5A). However,
all Ahp1 variants exhibited estimated molecular weights lower than
that of a dimer, with most (except for F95A) approximately the value of
a His-tagged Ahp1 monomer (~23.3 kDa) (Fig. 5A). In sum, our data
confirm that substitution of subunit interface residues decreases the
ability of Ahp1 to form dimers. Since the Ahp1 interface mutants dis-
rupted oligomerization, we tested their peroxidase performance in a
coupled activity assay with thioredoxin Trx2, thioredoxin reductase
Trr1 and NADPH (Fig. 5B). Upon addition of t-BOOH, a sharp decrease
in NADPH occurred for wild-type Ahp1 diagnostic for proper peroxide
detoxification (Fig. 5B). In contrast, Ahp1 variants harboring single and
double substitutions at the dimer interface resembled inactive enzymes
lacking the crucial CP or CR thiols (C62S or C31S) (Fig. 6B).
Thus, our data show that the hydrophobic interface contributes to
the ability of Ahp1 to form dimers and detoxify t-BOOH in vitro. In
contrast to wild-type Ahp1, we observed by anti-HA and anti-Ahp1
EMSAs that the single (F58A; F95A) and double (F58,95A) interface
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mutants failed to be urmylated and lacked formation of Ahp1 inter-
subunit disulfides under non-reducing conditions (Fig. 5C). This shows
an intact dimer interface is critical for anti-oxidant activity of Ahp1 and
Urm1 conjugation. In line with this, the Phe-95 substitution alone or in
tandem with the Phe-58 mutation were reported to enhance the sen-
sitivity of yeast cells to growth inhibition by t-BOOH in vivo [14]. To-
gether, our data demonstrate that dimerization and peroxidase activity
are intimately linked with urmylation of Ahp1.
2.5. Mutagenesis of the redox-active thiol center in Ahp1 abolishes
urmylation
Ahp1 was shown to be urmylated at Lys-32 close to its redox-active
center (Cys-31 Cys-62) (Fig. 1B) [12,15,16,21]. Another cysteine re-
sidue (Cys-120) was assumed to be catalytic [16] before being refuted
[15]. We examined whether serine substitution mutations at Cys-31,
Cys-62 or Cys-120 would affect the sensitivity of an ahp1Δ null-mutant
towards t-BOOH in vivo. Expression of C31S and C62S mutants failed to
restore t-BOOH protection in ahp1Δ cells, while Ahp1 wild-type and the
C120S mutant allowed for growth at t-BOOH doses of up to 2 mM
(Suppl. Fig. S2). Yeast lacking Ahp1 and the oxidant-sensitive tran-
scription factor Yap1 (yap1Δahp1Δ) are more sensitive to t-BOOH [39]
than ahp1Δ cells. Expression of the C62S mutant in this background
failed to protect against 0.9 mM t-BOOH, a dose tolerated by the C31S
mutant (Fig. 6A). Hence, in the absence of Yap1, the importance of the
CR and CP thiols for peroxidase activity apparently differs. Since t-
BOOH tolerance was eliminated after substituting both redox-active
thiols (C31,62S) in the double mutant (Fig. 6A), partial peroxidase
activity seen with the C31S mutant alone depends on an active CP (Cys-
62). Therefore, unlike Cys-31, Cys-62 is critical for anti-oxidant func-
tion of Ahp1. The C120S mutant, however, did not noticeably alter t-
BOOH sensitivity (Fig. 6A) and combined with the CR or CP mutations
(C31,120S or C62,120S), there are no additional growth defects com-
pared to the single C31S or C62S mutants alone (Fig. 6A) (Suppl. Fig.
S2).
Our in vivo data are in agreement with in vitro Ahp1 peroxidase
activity assays (Fig. 6B). Upon addition of t-BOOH, we observed a
marked decrease in NADPH indicative for peroxide detoxification by
wild-type Ahp1 and the C120S mutant, while peroxidase activity with
C31S or C62S was negligible (Fig. 6B). In addition, we found wild-type
Fig. 3. Suppression of Ahp1 urmylation
and disulfide formation by t-BOOH in
vivo. Shown are EMSAs under reducing
(left panels) and non-reducing (right
panels) conditions from strains treated
with t-BOOH as indicated and expres-
sing HA-URM1 (+) or not (−). NEM-
stabilized HA-Urm1 conjugation was
studied by anti-HA blots (top panels)
diagnostic for free HA-Urm1 and ur-
mylated forms of Ahp1 (~36 kDa) and
Ahp1 intersubunit disulfides (AID
~72 kDa). anti-Ahp1 blots (middle pa-
nels) detect unmodified Ahp1
(~19 kDa) and AID (~38 kDa). anti-
Cdc19 (bottom panels) served as in-
ternal standard.
Fig. 4. Effects of t-BOOH on Ahp1 re-
duction by thioredoxin and integrity of
the thiocarboxylate of Urm1. (A)
Inhibition of Ahp1 urmylation by t-
BOOH relies on a functional thior-
edoxin reductase. EMSA under non-re-
ducing conditions from TRR1 and trr1Δ
cells expressing HA-URM1 (+) or not
(−) in the presence (+) or absence (−)
of 5 mM t-BOOH. HA-Urm1 conjugation
was studied by anti-HA Western blot
(top panel) diagnostic for free HA-Urm1
and urmylated forms of Ahp1
(~36 kDa) and Ahp1 intersubunit dis-
ulfides (AID ~72 kDa). The anti-Ahp1
blot (bottom panel) detects unmodified
Ahp1 (~19 kDa) and AID (~38 kDa).
Asterisks denote faster Ahp1 forms
(bottom panel) in trr1Δ cells and an
unknown anti-HA signal (top panel).
(B) t-BOOH exposure of Urm1 in vitro. Recombinant Urm1-COSH was treated with indicated t-BOOH doses and analyzed under non-reducing conditions by APM gel
electrophoresis at time-point 0 min (middle panel) and 30 min (top panel) and under reducing SDS-PAGE conditions in the absence of APM after 30 min (bottom
panel). Arrows distinguish the thiocarboxylate (Urm1-COSH) from the inactive form (Urm1-COOH).
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like urmylation levels including formation of urmylated (or non-mod-
ified) Ahp1 intersubunit disulfides in the Cys-120 mutant (Fig. 6C).
Next, we asked whether CR (C31S) and/or CP (C62S) substitutions
would affect Ahp1 oxidation and urmylation. As judged from anti-Ahp1
EMSA, the Cys-31 and Cys-62 substitutions alone (C31S; C62S) or in
combination (C31,62S; C31,120S; C62,120S) all failed to form Ahp1
intersubunit disulfides under non-reducing conditions (Fig. 6C). This
agrees with our data (Fig. 6A and B) showing that the CR and CP thiols
are key to the Ahp1 peroxidatic cycle (Fig. 1B). However, based on anti-
HA EMSA, each mutation behaved different in terms of urmylation
(Fig. 6C). While single C31S and double C31,120S mutants formed
Urm1 conjugates under reducing and non-reducing conditions, C62S
failed to do so.
This indicates that disulfide formation upon oxidation is dispensable
for urmylation, whereas the CP thiol (Cys-62) is essential for the con-
jugation reaction (Fig. 6C). Accordingly, when combined with C31S or
C120S, the negative C62S effect dominates causing loss of urmylation in
each double mutant (C31,62S or C62,120S) (Fig. 6C). Thus, Cys-62 is
essential for urmylation even in the case of the C31S mutant, which
lacks disulfide formation upon oxidation by the peroxide and cannot be
recycled. This finding indicates that oxidation of Cys-62 rather than
disulfide formation upon Cys-62 oxidation is critical for urmylation.
2.6. Analysis of lysine-based acceptor sites for urmylation of Ahp1
To monitor a possible link between the redox-active center in Ahp1
and lysine-directed Urm1 conjugation, we studied the impact of lysine
substitutions in Ahp1 on urmylation. The proximity of Lys-32 and Lys-
156 (Fig. 7A) to the catalytic thiols in the crystal structure of Ahp1 [15]
prompted us to generate mutants with both replaced by arginine alone
or in combination (K32R; K156R; K32,156R). We observed slightly
decreased urmylation levels in the K156R mutant compared to wild-
type suggesting a minor target role (Fig. 7B).
Unlike previously reported [21], urmylation in the K32R mutant
was not entirely abolished, but was significantly decreased compared to
wild-type or K156R cells (Fig. 7B). This indicates Lys-32 is targeted
more easily by Urm1 than Lys-156, yet it is not essential to provide
Ahp1 with full Urm1 acceptor activity. Strikingly, the absence of both
residues in the double mutant (K32,156R) enhanced the urmylation
defects of each single mutant (K32R or K156R) (Fig. 7B). As a result,
Urm1 conjugation dropped to significantly low levels, albeit not as
dramatic as with complete loss of urmylation seen in the peroxidase-
dead mutant (C62S) (Fig. 7B). This additive negative effect suggests
that Lys-156 is an alternative urmylation site, particularly when Lys-32
is unavailable due to a substitution mutation. Moreover, based on low
residual urmylation left in the double mutant (K32,156R) the existence
of other Urm1 target sites has to be assumed.
Hence, we consider lysine-directed Urm1 conjugation to Ahp1 may
be promiscuous and less specific to Lys-32 than originally [21] an-
ticipated. Urmylation at lysine residues next to the catalytic thiols may
interfere with the anti-oxidant activity of Ahp1. Therefore, we ex-
amined whether the K32R, K156R and K32,156R mutants would affect
t-BOOH sensitivity in vivo in relation to peroxidase-minus (C62S) or
URM1 and YAP1 URM1 deletion strains (Fig. 7C). In the yap1Δahp1Δ
strain, the K32R, K156R and K32,156R mutants all restored t-BOOH
tolerance similar to that of wild-type AHP1 (Fig. 7C). This is in con-
trast to the peroxidase-dead mutant (C62S), which fails to change the
t-BOOH sensitivity and lacks urmylation (Fig. 7B and C). Together
with t-BOOH sensitivity of the yap1Δurm1Δ double mutant (Fig. 7C),
our data thus indicate that the lysine substitution mutants do not
significantly differ in their response to t-BOOH cytotoxicity from
yap1Δ cells that express wild-type Ahp1 but cannot undergo protein
urmylation due to URM1 gene deletion. Hence, lysine dependent ur-
mylation defects (K32R; K32,156R) appear not to affect the anti-
Fig. 5. Ahp1 dimer interface mutations block peroxidase activity and urmylation. (A) Analysis of oligomeric state for Ahp1 variants by SEC-MALS. Traces represent
A280 values of prominent peaks eluting off of the gel filtration column, and the scatter plotters underneath indicate the molecular weight (MW) ranges observed. The
average molecular weight is given for the wild-type (wt) Ahp1 dimer and each interface mutant. (B) Coupled Ahp1 activity assays (see Materials & Methods). At
180 s, t-BOOH (100 μM) was added and NADPH absorbance at 340 nm monitored. An average of six independent measurements ± standard error of the mean is
represented. (C) EMSA under non-reducing conditions from indicated strains expressing HA-URM1 (+) or not (−). NEM-stabilized urmylation was studied by anti-
HA blot (top panel) diagnostic for free HA-Urm1 and urmylated forms of Ahp1 (~36 kDa) and Ahp1 intersubunit disulfides (AID ~72 kDa). anti-Ahp1 blot (middle
panel) detects unmodified Ahp1 (~19 kDa) and AID (~38 kDa). Protein loading control: anti-Cdc19 (bottom panel).
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oxidant activity of Ahp1.
In agreement with our mutational analysis of the redox-active cy-
steines above (Fig. 6), we confirmed that for lysine-directed Urm1
conjugation to occur, Ahp1 must be catalytically active (Fig. 7D). Thus,
residual urmylation levels typical of the lysine substitution mutants
(K32R; K156R; K32,156R) (Fig. 7B) were found to be abolished upon
mutation of the CP thiol (C62S) rather than the CR thiol (C31S)
(Fig. 7D). In further support of this view are studies with the human
homolog of Urm1 (hURM1), which we had previously shown to modify
Ahp1 in yeast [20]. Here, our data show that, as is the case with yeast
Urm1, the ability of hURM1 to form lysine-directed conjugates depends
on the integrity of the CP thiol (Cys-62) and hence, on the anti-oxidant
activity of Ahp1 (Suppl. Fig. S3).
3. Discussion
Unlike conventional ubiquitin-like proteins (e.g. SUMO, Nedd8,
UFM1), Urm1 undergoes activation by C-terminal thiocarboxylation
(Urm1-COSH) [29,44,45]. Thus thiolated Urm1 is dual-functional, en-
gaging in two sulfur-dependent modification pathways, namely tRNA
thiolation and ubiquitin-like Urm1 conjugation [46–49]. While the
former function resembles bacterial sulfur carriers (e.g. ThiS-COSH or
MoaD-COSH) engaged in thio-cofactor synthesis (e.g. thiamin or mo-
lybdopterin) [46–48,50,51], the latter involves oxidant-induced, lysine-
directed protein urmylation in eukaryotes [17,21,52]. Similarly, pro-
karyotic Urm1-like proteins (e.g. TtuB, SAMP1-SAMP3) with dual
modification functions have been identified, and Urm1-like conjugation
including archaeal sampylation can be triggered by oxidants, too
[19–21,32,33]. This suggests a conserved function of Urm1 family
members in oxidative stress responses, and indeed among identified
Urm1 targets from yeast, fungi, flies and human cells are 2-Cys per-
oxiredoxins (Ahp1, Prx5) [18–22,32,33].
The redox requirements of Ahp1 and molecular determinants that
influence its urmylation are largely unknown. Our analyses of un-
modified and urmylated Ahp1 under reducing or non-reducing condi-
tions show that only a fraction of Ahp1 is subject to urmylation in vivo.
Thus, under our experimental conditions, Ahp1 urmylation is not lim-
iting, a notion in accordance with quantitative proteomic studies
showing that in budding yeast, Ahp1 is considerably more abundant
than Urm1 [53]. In contrast to canonical ubiquitination [54], we find
no evidence for oligo- or poly-urmylation, and among the urmylated
pool are Ahp1 intersubunit disulfides, which carry one Urm1 copy at-
tached to each subunit. Since we are not aware of a deurmylase activity
from yeast (or other model systems), it remains to be elucidated whe-
ther Urm1 is permanently attached to Ahp1.
In addition, we show that treatment of yeast cells with high t-BOOH
concentrations decreases urmylation of Ahp1 (Fig. 3). This negative
effect of t-BOOH on urmylation requires a proper thioredoxin system
(Trr1, Trx1, Trx2; Fig. 2 and 4A). In the absence of cytosolic thior-
edoxins or thioredoxin reductase, Ahp1 should be more frequently in
the disulfide-linked state, thereby preventing hyperoxidation. Con-
sistent with this notion, peroxiredoxins that more quickly resolve to
form the disulfide upon sulfenic acid formation are more resistant to
hyperoxidation [55,56]. In contrast, continuous reduction by thior-
edoxin may increase the chance of hyperoxidation, as is the case for
other peroxiredoxins [39,55–60]. The anti-oxidant activity of Ahp1
Fig. 6. AHP1 mutational analysis links
Urm1 acceptor activity with peroxiredoxin
function. (A) t-BOOH cytotoxicity assay in
vivo. Growth of ahp1Δ or yap1Δahp1Δ cells
carrying empty vector (ev), wild-type per-
oxiredoxin gene (AHP1) or indicated Cys
substitutions was monitored without or with
0.9 mM t-BOOH. (B) Coupled Ahp1 activity
assays. At 180 s, t-BOOH (100 μM) was
added and NADPH absorbance at 340 nm
monitored. An average of six independent
measurements ± standard error of the mean
is represented. (C) EMSA under reducing
(left panels) and non-reducing (right panels)
conditions from indicated genetic strain
backgrounds expressing HA-URM1 (+) or
not (−). NEM-stabilized HA-Urm1 con-
jugation was studied by anti-HA blots (top
panels) diagnostic for free HA-Urm1 and
urmylated forms of Ahp1 (~36 kDa) or
Ahp1 intersubunit disulfides (AID
~72 kDa). anti-Ahp1 Western blots (middle
panels) solely detect unmodified Ahp1
(~19 kDa) and AID (~38 kDa). Western
blots using anti-Cdc19 (bottom panels)
served as internal protein standard.
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requires a constitutive homodimer, in which two subunits generate the
2-Cys-based redox-active (Cys-31 Cys-62) centers (Fig. 1A and B)
[14,15,43]. Assembly of active peroxiredoxin through a well-defined
hydrophobic subunit interface in the Ahp1 dimer (Phe-58, Phe-95)
(Fig. 1A and B) [14] apparently is a prerequisite for Urm1 conjugation
in vivo. Hence, interface mutants of Ahp1 (F58A; F95A; F58,95A) which
no longer form dimers fail to be urmylated, even in the presence of the
catalytic Cys residues (Fig. 5C). Nevertheless, substituting the cataly-
tically critical CP thiol (C62S) alone or in tandem with the CR thiol
(C31,62S) or a third thiol (C62,120S) leads to peroxidase-dead enzymes
that lack urmylation (Fig. 6C). Hence, the integrity of Cys-62, which
upon sulfenylation by t-BOOH forms with Cys-31 the intersubunit dis-
ulfides (Fig. 1B) [15,16,57,59], is essential for both peroxide detox-
ification and Ahp1 urmylation.
Despite such strict dependence on the CP thiol (Cys-62), Ahp1 ur-
mylation after all results in ubiquitin-like, lysine-directed protein con-
jugation [21,61]. Given that Cys residues can be ubiquitinated [62–64],
primary Urm1 transfer onto Ahp1 may involve a non-lysine site (i.e.
Cys-62) followed by subsequent lysine-directed iso-peptide linkage. If
so, it will be important to delineate the redox state of Cys-62 required
for Urm1 transfer. That oxidation may be important is supported by
data showing thiol-active agents (H2O2, t-BOOH, diamide, NEM) trigger
urmylation of proteins including peroxiredoxins Prx5 and Ahp1
[19–21,32,33].
In principle, the thiolate that Cys-62 forms in its reduced state may
react with the thiocarboxylate of Urm1 (Urm1-COSH) to produce a
thioester. However, taking into account that in its reduced state, Ahp1
is fully folded [12,65], the thiol of Cys-62 may not be accessible
without local unfolding for Urm1-COSH transfer. CP thiol (Cys-62)
oxidation and sulfenylation (-SOH) by peroxide (Fig. 8) could facilitate
unfolding and prime the formation of an acyl disulfide between Ahp1
and Urm1 (Ahp1-S-S–CO–Urm1) rather than the above thioester. From
organic chemistry in vitro it is known that acyl disulfides, which form
between the thiocarboxylate of one peptide and an activated thiol of a
second carrying a free amino group, are short-lived and readily ligate
via iso-peptide bonds [66–68]. In analogy, we envision that the acyl
disulfide (Ahp1-S-S–CO–Urm1) formed in vivo is highly reactive and
undergoes a nucleophilic attack on its carbonyl group by the ε-amino
group of a nearby lysine residue (Fig. 8). This will generate an iso-
peptide bond with Urm1 (Ahp1-NH–CO–Urm1) and leave the perox-
idatic cysteine persulfidated (Cys-S-SH) (Fig. 8). Whether Lys-based
urmylation stabilizes this persulfide on Ahp1 for trans-persulfidation of
other targets is not known (Fig. 8).
In line with our working model (Fig. 8), a previous report [21]
showed that among ten out of fourteen lysines tested for Ahp1 target
site function, Lys-32 (next to Cys-31) is necessary for iso-peptide
linkage with Urm1. However, we find that Lys-32 substitution alone
(K32R) or in tandem with Lys-156 (K32,156R), which maps proximal to
the CP thiol (Cys-62) (Fig. 7A), still allows residual urmylation. So,
rather than being essential, Lys-32 likely represents one of several
target sites for Urm1 conjugation with Ahp1. In support of promiscuous
lysine sites, which from conventional ubiquitylation substrates in yeast
(e.g. Sic1, Rpn4) [69–71] are not unheard of, we observe a minor Urm1
target role for Lys-156, and two more lysine residues, Lys-102 and Lys-
107, can be found proximal to the active site in Ahp1 (Fig. 7A).
Although Urm1 is conserved in eukaryotes [20,34], the precise role
the modifier plays for its target proteins is ill-defined. As for Ahp1, we
have shown here that substitutions of the lysine-based urmylation sites
(K32R; K32,156R) exhibit negligible effects on the anti-oxidant activity
of the enzyme in vivo while peroxidase-dead mutants (C62S; C31,62S;
C62,120S) all fail to be urmylated. Nonetheless, Urm1 attachment oc-
curs close to the redox-active (Cys-31 Cys-62) center (Fig. 1A and B)
Fig. 7. Lysine-directed Ahp1 urmylation in
vivo requires the catalytic CP thiol (Cys-62).
(A) Overview of lysine residues (K32, K102,
K107, K156) close to the redox-active center
in the reduced form of the Ahp1 homodimer
(see Fig. 1A and B). (B, D) Shown are EMSAs
under reducing conditions from the in-
dicated strains expressing HA-URM1 (+) or
not (−). NEM-stabilized HA-Urm1 con-
jugation was studied by anti-HA blot (top
panels) diagnostic for free HA-Urm1 and
urmylated Ahp1 (~36 kDa). anti-Ahp1
Western blot (middle panels) detects un-
modified Ahp1 (~19 kDa); anti-Cdc19
(bottom panels) served as internal standard.
(C) t-BOOH cytotoxicity assay in vivo.
Growth of ahp1Δ or yap1Δahp1Δ cells car-
rying empty vector (ev), wild-type peroxir-
edoxin gene (AHP1) and cysteine or lysine
substitutions was monitored together with
urm1Δ and yap1Δurm1Δ reference cells
without or with the indicated t-BOOH doses.
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and near the Ahp1-Trx2 interface [15], which is why urmylation cannot
be excluded to interfere with some aspect of the Ahp1 peroxidatic cycle
(e.g. t-BOOH detoxification or thioredoxin reduction; Fig. 1B). In sup-
port, Ahp1 regeneration by Trx2 has been shown to be affected in Lys-
32 substitution mutants (K32A; K32E) in vitro [15]. Bearing in mind
that a bacterial sulfur carrier with an Urm1-like fold (CysO-COSH) is
more resistant to oxidation than sulfide and upregulated by oxidative
stress [72], the role for yeast Urm1-COSH may also relate to peroxides,
in particular t-BOOH, the preferred substrate of Ahp1 [11,12]. The
latter notion agrees with our in vivo studies showing that while Urm1
conjugation was detectable in response to mild and intermediate t-
BOOH doses, higher peroxide levels gradually prevented urmylation
and significantly decreased Ahp1 disulfide formation.
We cannot exclude that inactivation by t-BOOH of Ahp1 or Urm1-
COSH itself may impede urmylation of the peroxiredoxin in vivo.
However, Ahp1 has been co-purified with a sulfiredoxin (Srx1) capable
to reduce hyperoxidized Tsa1 [73], a distantly related 2-Cys peroxir-
edoxin [43]. Moreover, in vitro we found indications for peroxide in-
activation of Urm1-COSH (Fig. 4B) suggesting this may constitute a
factor accounting for the negative t-BOOH effects on Ahp1 redox
biology and urmylation (Fig. 3). In sum, our comprehensive urmylation
analysis of the 2-Cys peroxiredoxin Ahp1 has laid the foundation to
better understand the redox requirements for Urm1 conjugation in vivo
and provide insight into the mechanism for urmylation of other protein
targets.
4. Material and methods
4.1. Yeast strains, plasmid constructions and general methods
Growth of yeast strains (Table S1) was in routine YPD or SC media
[74] for 3 days at 30 °C. Primers used for PCR-based protocols [75–78]
to generate and diagnose site-specific AHP1 mutations, gene deletions
or epitope tagged gene fusions are listed in Table S2. PCR-based site-
directed mutagenesis (SM-PCR [79]) for generation of Ahp1 cysteine to
serine (C31S, C62S, C120S), phenylalanine to alanine (F58A, F95A) and
lysine to arginine (K32R, K156R) substitutions or double combinations
thereof (C31,62S; C31,120S; C62,120S; F58,95A, K32,156R, C31S/
K32R, C31S/K156R, C62S/K32R, C62S/K156R, C31S/K32,156R) was
as previously described using single-copy expression plasmids [80]
(Table S3) and verified by Sanger based DNA sequencing. For AHP1
expression in yeast, the ORF of AHP1 and variants were amplified by
PCR from chromosomal DNA of yeast strain BY4741 (Table S1) and
cloned into YCplac111 generating pAJ31. Epitope-tagged AHP1-(c-
myc)9 was amplified from chromosomal DNA of strain FEY14 [20]
(Table S1) and cloned into YCplac111 to generate pAJ19. Transfor-
mation of yeast cells with PCR products or plasmids [80,81] was done
as previously described [82,83]. t-BOOH toxicity assays in vivo involved
BY4741, ahp1Δ or ahp1Δyap1Δ strains transformed with empty vector
(YCplac111) or Ahp1 expression constructs (Table S1). These were di-
luted to an OD600 of 1.0 from which 10-fold serial dilutions were
spotted onto YPD plates in the absence or presence of 0.6–2.0 mM t-
BOOH (tert-butyl hydroperoxide, Sigma) and grown for 36–48 h at
30 °C.
4.2. Urmylation studies using electrophoretic mobility shift assays (EMSA)
Urmylation studies were done essentially as described [20] with
yeast grown in standard SC media at 30 °C to an OD600 of ~1.0. Cell
lysis was done with a bead beater in a buffer (10 mM K-HEPES pH 7.0,
10 mM KCl, 1.5 mM MgCl2, 0.5 mM PMSF, 2 mM benzamidine, com-
plete protease inhibitors (Roche) and 10 mM N-ethylmaleimide (NEM))
as previously described [18,20]. In some experiments, the cell culture
was pre-incubated with t-BOOH (0.3–10 mM) for 5 min immediately
before lysis. Following centrifugation at 16.000g, protein concentration
in the supernatant was determined according to Bradford [84]. The
lysates were mixed with sample buffer (62.5 mM Tris-HCl pH 6.8, 2%
SDS, 10% glycerol, 0.002% bromophenol blue and ±5% β-mercap-
toethanol) according to Lämmli [85], subjected to SDS-PAGE and
transferred onto PVDF membranes. For EMSAs and Western blot ana-
lyses, PVDF membranes were incubated with primary anti-HA anti-
bodies (F7, Santa Cruz Biotechnology or 2–2.214 Invitrogen). Un-
conjugated Ahp1 samples were probed with anti-Ahp1 serum [39]
kindly provided by Dr Kuge (Tohoku Pharmaceutical University, Japan)
and horseradish peroxidase-conjugated secondary goat anti-mouse or
anti-rabbit IgGs (Jackson ImmunoResearch). Protein loading was
checked using anti-Cdc19 antibodies provided by Dr Thorner (Uni-
versity of California-Berkeley, USA).
4.3. Expression and production of thiocarboxylated Urm1
In order to obtain thiocarboxylated Urm1, the Urm1-Intein-CBD-
His6 fusion protein was overexpressed in E. coli and purified according
to Refs. [29,86] with modifications. In brief, the bacterial pellet was
resuspended in lysis buffer without reducing agent and lysed to
homogeneity. The lysate was passed through a Ni-NTA column and,
following washes, the fusion protein was eluted with elution buffer
(30 mM Tris-HCl pH 7.5; 300 mM NaCl; 250 mM imidazole and 10%
glycerol). The eluates were dialyzed overnight to chitin column buffer
(30 mM Tris-HCl pH 8 and 500 mM NaCl) and applied on a chitin
column. The column was washed with chitin column buffer and the
cleavage of the tag was induced through incubation with cleavage
buffer (30 mM Tris-HCl pH 8; 500 mM NaCl and 35 mM ammonium
sulfide) for 16 h at room temperature. This procedure leads to the
formation of Urm1 without additional residues at the N-terminus and
with a thiocarboxylated C-terminal glycine (Urm1-COSH). The eluted
Fig. 8. Working model for ubiquitin-like urmylation of yeast peroxiredoxin Ahp1. Step 1: The peroxidatic thiol of Ahp1 (Cys-SH) reacts with a peroxide to form a
sulfenic acid (Cys-SOH), which following the fully folded to locally unfolded (FF-LU) transition [59] may become surface exposed. Step 2: The sulfenic acid (Cys-
SOH) condenses with the activated thiocarboxylate of Urm1 (Urm1-COSH) to form an acyl disulfide (Ahp1-S-S–CO–Urm1). Step 3: The ε-amino group of a nearby Lys
residue mounts a nucleophilic attack on the carbonyl group of the acyl disulfide generating an iso-peptide bond (Lys–NH–CO-Urm1) between Ahp1 and Urm1 and a
persulfidated cysteine (Cys-S-SH). Whether Lys-based urmylation stabilizes the persulfide on Ahp1, triggers H2S-release or drives trans-persulfidation of other targets
is not known. For simplicity, the mechanistic hypothesis involves only one subunit of the Ahp1 homo-dimer.
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Urm1-COSH was further purified by size-exclusion chromatography on
a HiLoad 16/600 Superdex 75 column on ÄKTA™ start system and
stored at −80 °C in storage buffer (20 mM Tris pH 7.5 and 200 mM
NaCl). The presence of thiocarboxylated C-terminus was confirmed by
running the protein on a polyacrylamide gel containing 25 μM APM
([N-Acryloyl-amino] phenyl) mercuric chloride [21,42].
4.4. Bacterial protein expression and purification of Ahp1
Procedures for cloning bacterial expression constructs for Trx2 and
Ahp1 in the vector pET45b have been reported previously [14,87]. The
Trr1 was amplified out of S. cerevisiae genomic DNA (Primer listed in
Table S2). The PCR product was digested with NdeI and XhoI and
subsequently cloned into pET29a with a C-terminal His tag. All clones
were validated by DNA sequencing. Procedures for expressing and
purifying His-tagged Ahp1 and Trx2 proteins have been reported pre-
viously [14,88]. A similar procedure was followed for the expression
and purification of Trr1. Briefly, E. coli Rosetta cells transformed with
pET29a-Trr1 were grown to mid-log phase in 400 mL LB medium
containing 100 μg/mL ampicillin. Trr1 expression was induced with
1 mM IPTG for 6 h at 37 °C. Proteins were purified from cell pellets
using the Qiagen NiNTA Fast-Start kit. Eluted proteins were desalted
using PD Minitrap G25 column equilibrated with TDG buffer (50 mM
Tris pH 7.5, 2 mM DTT, 10% glycerol and protease inhibitor cocktail (G
Biosciences)). Proteins were estimated to be >95% pure by reducing
SDS-PAGE. Extinction coefficients for proteins were estimated from the
protein coding sequences as follows: Ahp1 (37950 M−1 cm−1), Trx2
(18,020 M−1 cm−1), and Trr1 (24719 M−1 cm−1).
4.5. Analysis of oligomeric state of Ahp1-dimer interface variants
Size exclusion chromatography coupled with multiangle light scat-
tering (SEC-MALS) was used to monitor oligomeric state of Ahp1 pro-
teins. Briefly, proteins were reduced in TDG by adding additional DTT
to a final concentration of 50 mM and incubating for 30 min at room
temperature. Reduced proteins were exchanged into SEC-MALS buffer
(20 mM HEPES pH 7.5, 100 mM NaCl and 1 mM TCEP) using a BioSpin
6 column and diluted to 125 μM. Proteins were resolved on a gel fil-
tration column and analyzed by MALS as previously described [43].
4.6. Analysis of Ahp1 peroxidase activity
Ahp1 variants (50 μL) were reduced with 50 mM DTT for 1 h at
room temperature, prior to buffer exchange into 50 mM HEPES (pH
8.0) using a Biospin 6 column (BioRad). Activity assays were conducted
using a coupled activity assay with t-BOOH, Trx2, Trr1 and NADPH
[15]. Briefly, assays were conducted in 50 mM HEPES (pH 8.0) con-
taining 0.5 μM Ahp1, 0.5 μM Trx2, 0.5 μM Trr1, and 125 μM NADPH.
Prior to t-BOOH addition, a baseline reading was obtained every 30 s.
At 180 s, 100 μM t-BOOH was added, and reactions were monitored at
A340 every 30 s for 420 s.
4.7. In vitro t-BOOH response assay
500 ng of thiocarboxylated Urm1 was mixed in reaction buffer
(20 mM Tris pH 7.5 and 200 mM NaCl). 0–10 mM tBOOH, was included
and excluded as indicated. The reaction mix was incubated for 30 min
at 30 °C, stopped by adding Lämmli sample buffer ± DTT and in-
cubated for 5 min at 95 °C. Subsequently the thiocarboxylated Urm1
samples were loaded on SDS-PAGE gel containing 25 μM APM or not.
For protein visualization, the gels were stained with Coomassie Brilliant
Blue.
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